Haemonetics Corp (HAE)
95.76
+0.96
(+1.01%)
USD |
NYSE |
May 17, 16:00
95.76
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Accounts Payable (Quarterly): 56.84M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 56.84M |
September 30, 2023 | 80.16M |
June 30, 2023 | 78.13M |
March 31, 2023 | 63.93M |
December 31, 2022 | 63.77M |
September 30, 2022 | 61.48M |
June 30, 2022 | 57.91M |
March 31, 2022 | 58.37M |
December 31, 2021 | 51.18M |
September 30, 2021 | 44.97M |
June 30, 2021 | 49.13M |
March 31, 2021 | 50.29M |
December 31, 2020 | 42.98M |
September 30, 2020 | 49.07M |
June 30, 2020 | 48.46M |
March 31, 2020 | 50.73M |
December 31, 2019 | 52.30M |
September 30, 2019 | 57.45M |
June 30, 2019 | 60.79M |
March 31, 2019 | 63.36M |
December 31, 2018 | 62.58M |
September 30, 2018 | 57.86M |
June 30, 2018 | 65.39M |
March 31, 2018 | 55.26M |
December 31, 2017 | 41.50M |
Date | Value |
---|---|
September 30, 2017 | 41.76M |
June 30, 2017 | 39.39M |
March 31, 2017 | 42.97M |
December 31, 2016 | 48.85M |
September 30, 2016 | 42.01M |
June 30, 2016 | 36.80M |
March 31, 2016 | 39.67M |
December 31, 2015 | 39.64M |
September 30, 2015 | 42.09M |
June 30, 2015 | 42.16M |
March 31, 2015 | 48.42M |
December 31, 2014 | 46.83M |
September 30, 2014 | 44.17M |
June 30, 2014 | 55.21M |
March 31, 2014 | 53.56M |
December 31, 2013 | 43.11M |
September 30, 2013 | 45.38M |
June 30, 2013 | 47.92M |
March 31, 2013 | 49.89M |
December 31, 2012 | 53.08M |
September 30, 2012 | 42.99M |
June 30, 2012 | 33.98M |
March 31, 2012 | 35.42M |
December 31, 2011 | 28.89M |
September 30, 2011 | 29.76M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
42.98M
Minimum
Dec 2020
80.16M
Maximum
Sep 2023
56.73M
Average
56.84M
Median
Dec 2023
Accounts Payable (Quarterly) Benchmarks
Stryker Corp | 1.246B |
ResMed Inc | 177.44M |
Masimo Corp | 203.10M |
Insulet Corp | 75.90M |
InfuSystems Holdings Inc | 9.796M |